Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 988 clinical trials
featured
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis

participants who are biologic-naive and biologic-experienced. Participants who complete the study, or do not meet protocol response or remission criteria at Week 10 will have the option to enter a

vedolizumab
tumor necrosis factor alpha
corticosteroids
immunomodulators
remission
  • 2036 views
  • 26 Apr, 2019
  • 1 location
featured
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

participants who are biologic-naive and biologic-experienced. Participants who complete the study, or do not meet protocol response or remission criteria at Week 10 will have the option to enter a

remission
ustekinumab
corticosteroids
maintenance treatment
tumor necrosis factor
  • 2194 views
  • 08 May, 2018
  • 1 location
featured
ECO-RESET: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Multicenter Study to Assess Efficacy and Safety of SER-287 in Adults with Active Mild-to-Moderate Ulcerative Colitis

To demonstrate the efficacy of study drug, SER-287, to induce clinical remission in patients with active mild-to-moderate ulcerative colitis.  

tumor necrosis factor
corticosteroids
endoscopy
remission
  • 219 views
  • 23 Nov, 2020
  • 1 location
featured
Immune modification of psoriasis by selective IL-23 blockade using risankizumab

Researchers at The Rockefeller University Hospital are conducting a study to explore long-term disease remission of psoriasis with short-term treatment with Risankizumab (SKYRIZITM) - an FDA

  • 0 views
  • 06 Apr, 2021
  • 1 location
featured
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Giant Cell Arteritis

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Giant Cell Arteritis  

  • 52 views
  • 23 Nov, 2020
  • 1 location
featured
A3921210 OVATION  

equivalent if dose escalation criteria are met.The primary objective of this study is to evaluate the efficacy of tofacitinib based on remission in pediatric participants with moderately to severely

mercaptopurine
prednisone
cancer
azathioprine
budesonide
  • 0 views
  • 14 Jun, 2021
  • 1 location
featured
Do you have ulcerative colitis in remission?

Do you have ulcerative colitis in remission?

  • 126 views
  • 08 Nov, 2020
  • 1 location
featured
Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn's Disease

participants who are biologic-naïve and biologic-experienced. Participants who complete the study, or do not meet protocol response or remission criteria at Week 10 will have the option to enter a

maintenance treatment
tumor necrosis factor
tumor necrosis factor alpha
corticosteroids
vedolizumab
  • 45 views
  • 11 Jun, 2020
  • 1 location
featured
Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy (Maintenance of Remission) and Safety of Etrolizumab Compared With Placebo in Patients With Moderate to Severe Active Ulcerative Colitis Who Are Naïve to TNF Inhibitors

Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy (Maintenance of Remission) and Safety of Etrolizumab Compared With Placebo in Patients With

  • 60 views
  • 25 Mar, 2021
  • 1 location
featured
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis

  • 248 views
  • 25 Mar, 2021
  • 1 location